The Invus Group is an investment firm that prefers to invest in companies operating in the consumer products and services, food, specialty retail, software, biotech, medical devices and products and professional service sectors across the United States and Europe. The firm was founded in 1985 and is headquartered in New York, New York.
Invus invests with flexibility in the types of companies and situations where they feel they can get involved with success for themselves and their portfolio companies.
Invus has been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.
A biotechnology startup company that develops messenger RNA based therapeutics to treat diseases.
A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.
AlloVir (formerly ViraCyte) is a company that develops cell therapies for patients suffering from life-threatening virus-associated diseases.
A biotechnology company making discoveries in genetic and metabolic diversity of the human microbiome into treatment and therapies for a wide range of diseases.
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
Generation Bio is a biotechnology company that was founded in 2016
Foghorn Therapeutics is a Cambridge, Massachusetts-based company developing gene-specific therapies.
PrimeraDx is a molecular diagnostics company that develops and commercializes a clinical platform
A company that focuses on discovery and development of prescription aesthetic medicine
TigerConnect is a healthcare focused secure communication and messaging company.
A biotechnology company developing immuno-oncology therapies and therapeutic vaccines
Locanabio is a San Diego, California-based biotechnology company developing RNA-targeting gene therapies.
Zenflow is a company developing a medical device to relieve BPH (benign prostatic hyperplasia) symptoms.
Seer is a Redwood City, California-based biotechnology company developing solutions for the proteomic industry founded by Omid Farokhzad.
Kronos Bio is a Cambridge, Massachusetts-based therapeutics company working on research and development of therapies that modulate historically recalcitrant cancer targets.
Scorpion Therapeutics is a Boston-based company founded in 2020.
Lyndra Therapeutics is a Watertown, Massachusetts-based company.
Future • Finance is a company founded by Vishal Garg.
ORIC Pharmaceuticals is a South San Francisco, California-based company.
A company offering a no-code development platform for automating digital processes.